Literature DB >> 2106258

Laboratory evaluation of jaundice in newborns. Frequency, cost, and yield.

T B Newman1, M J Easterling, E S Goldman, D K Stevenson.   

Abstract

Neonates with hyperbilirubinemia commonly undergo a battery of laboratory tests. We used a computerized database and medical records to study the frequency, cost, and yield of these tests in 2443 infants born at the University of California, San Francisco, between 1980 and 1982. Four hundred forty-seven (18%) of the infants met standard criteria for "nonphysiologic" hyperbilirubinemia; the incidence varied from 9% in blacks to 31% in Asian infants. About 55% of these 447 infants received a $125 "hyperbilirubinemia workup." Hospital discharge diagnoses on all 447 hyperbilirubinemic infants were reviewed. In 214 (48%), no cause of the jaundice was identified. An additional 145 (32%) had a possible cause apparent from history, physical examination, or initial hematocrit determination. The only diagnosis made as a result of routine investigations of hyperbilirubinemia was possible ABO or Rh isoimmunization in 75 infants (17%). Nonphysiologic hyperbilirubinemia may be more common than previously reported. The recommended tests are expensive and rarely lead to diagnoses other than ABO or Rh isoimmunization. Their routine use should be reevaluated.

Entities:  

Mesh:

Year:  1990        PMID: 2106258     DOI: 10.1001/archpedi.1990.02150270114039

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  8 in total

1.  Coombs' testing and neonatal hyperbilirubinemia.

Authors:  Stephen Wainer; Jack Rabi; Martha Lyon
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

2.  The African-American neonate at risk for extreme hyperbilirubinemia: a better management strategy is needed.

Authors:  W C Golden
Journal:  J Perinatol       Date:  2017-04       Impact factor: 2.521

Review 3.  Neonatal jaundice--a lighter touch.

Authors:  K L Dodd
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

4.  Phototherapy for neonatal hyperbilirubinemia and childhood eczema, rhinitis and wheeze.

Authors:  Elizabeth Huiwen Tham; Evelyn Xiu Ling Loo; Anne Goh; Oon Hoe Teoh; Fabian Yap; Kok Hian Tan; Keith M Godfrey; Hugo Van Bever; Bee Wah Lee; Yap Seng Chong; Lynette Pei-Chi Shek
Journal:  Pediatr Neonatol       Date:  2018-03-24       Impact factor: 2.083

5.  Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - Summary.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-05       Impact factor: 2.253

Review 6.  Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia.

Authors:  Ryoichi Fujiwara; Yoshihiro Maruo; Shujuan Chen; Robert H Tukey
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-02       Impact factor: 4.219

7.  A novel accurate LC-MS/MS method for quantitative determination of Z-lumirubin.

Authors:  Jana Jašprová; Aleš Dvořák; Marek Vecka; Martin Leníček; Ondřej Lacina; Petra Valášková; Miloš Zapadlo; Richard Plavka; Petr Klán; Libor Vítek
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

8.  The role of UGT1A1 (c.-3279 T > G) gene polymorphisms in neonatal hyperbilirubinemia susceptibility.

Authors:  Zijin Li; Li Song; Lihong Hao
Journal:  BMC Med Genet       Date:  2020-11-06       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.